BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10656218)

  • 1. Seropositivity to Helicobacter pylori and CagA protein in schoolchildren of different ages living in urban and rural areas in southern Estonia.
    Vorobjova T; Grünberg H; Oona M; Maaroos HI; Nilsson I; Wadström T; Covacci A; Uibo R
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):97-101. PubMed ID: 10656218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia.
    Vorobjova T; Nilsson I; Kull K; Maaroos HI; Covacci A; Wadström T; Uibo R
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):41-6. PubMed ID: 9512952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific serum immunoglobulin G to H pylori and CagA in healthy children and adults (south-east of Iran).
    Jafarzadeh A; Rezayati MT; Nemati M
    World J Gastroenterol; 2007 Jun; 13(22):3117-21. PubMed ID: 17589930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to Helicobacter pylori infection in children with intellectual disabilities.
    Douraghi M; Goudarzi H; Nateghi Rostami M; Nikmanesh B
    Res Dev Disabil; 2012; 33(2):663-9. PubMed ID: 22186633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects.
    Simán JH; Engstrand L; Berglund G; Florén CH; Forsgren A
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):304-9. PubMed ID: 15699426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of CagA and VacA proteins in Helicobacter pylori seropositive asymptomatic children in western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2005 Sep; 26(9):1372-7. PubMed ID: 16155650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders.
    Figura N; Di Cairano G; Lorè F; Guarino E; Gragnoli A; Cataldo D; Giannace R; Vaira D; Bianciardi L; Kristodhullu S; Lenzi C; Torricelli V; Orlandini G; Gennari C
    J Physiol Pharmacol; 1999 Dec; 50(5):817-26. PubMed ID: 10695561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
    Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
    Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Helicobacter pylori CagA antigen antibodies].
    Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
    Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of Helicobacter pylori infection prevalence in children in the contemporary period].
    Svarval' AV; Ferman RS; Zhebrun AB
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):83-8. PubMed ID: 22442977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Helicobacter pylori and cagA antibodies in Iceland, Estonia and Sweden.
    Thjodleifsson B; Asbjörnsdottir H; Sigurjonsdottir RB; Gíslason D; Olafsson I; Cook E; Gíslason T; Jogi R; Janson C
    Scand J Infect Dis; 2007; 39(8):683-9. PubMed ID: 17654344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori anti-CagA antibodies: prevalence in symptomatic and asymptomatic subjects in Turkey.
    Abasiyanik MF; Sander E; Salih BA
    Can J Gastroenterol; 2002 Aug; 16(8):527-32. PubMed ID: 12226680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High seroprevalence of Helicobacter pylori in chronic bronchitis among Chinese population.
    Jun ZJ; Lei Y; Shimizu Y; Dobashi K; Mori M
    Tohoku J Exp Med; 2006 Apr; 208(4):327-31. PubMed ID: 16565595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of anti-Helicobacter pylori and anti-CagA antibodies among healthy children according to age, sex, ABO blood groups and Rh status in south-east of Iran.
    Jafarzadeh A; Ahmedi-Kahanali J; Bahrami M; Taghipour Z
    Turk J Gastroenterol; 2007 Sep; 18(3):165-71. PubMed ID: 17891689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of infection with
    Muhsen K; Sinnereich R; Beer-Davidson G; Nassar H; Abu Ahmed W; Cohen D; Kark JD
    Epidemiol Infect; 2019 Sep; 147():e276. PubMed ID: 31552815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection.
    Torres J; Camorlinga-Ponce M; Perez-Perez G; Muñoz L; Muñoz O
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):97-100. PubMed ID: 11777836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of cagA and vacA seropositivity in asymptomatic Bangladeshi children with Helicobacter pylori infection.
    Sarker SA; Nahar S; Rahman M; Bardhan PK; Nair GB; Beglinger C; Gyr N
    Acta Paediatr; 2004 Nov; 93(11):1432-6. PubMed ID: 15513567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains.
    Perez-Perez GI; Salomaa A; Kosunen TU; Daverman B; Rautelin H; Aromaa A; Knekt P; Blaser MJ
    Gut; 2002 Mar; 50(3):295-8. PubMed ID: 11839704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histology and culture results among subjects with antibodies to CagA but no evidence of Helicobacter pylori infection with IgG ELISA.
    Ye W; Held M; Enroth H; Kraaz W; Engstrand L; Nyrén O
    Scand J Gastroenterol; 2005 Mar; 40(3):312-8. PubMed ID: 15932172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study.
    Schimke K; Chubb SA; Davis WA; Davis TM
    Atherosclerosis; 2010 Sep; 212(1):321-6. PubMed ID: 20839379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.